IRADIMED CORP
For the period ended Oct 30, 2026. Filed Oct 30, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Oct 30, 2026 · Filed Oct 30, 2026
Use the contents to explore the available documents and sections.
IRMD$86.31+0.9%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (in thousands, except per share data)
(in thousands, except per share data)
| Three Months EndedSeptember 30, | Nine Months EndedSeptember 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Revenue | $24,203 | $21,202 | $66,648 | $61,122 |
| Cost of revenue | 5,747 | 4,708 | 16,219 | 13,830 |
| Gross profit | 18,456 | 16,494 | 50,429 | 47,292 |
| Operating expenses: | ||||
| General and administrative | 4,533 | 4,356 | 12,967 | 13,246 |
| Sales and marketing | 4,909 | 4,631 | 13,207 | 12,817 |
| Research and development | 875 | 674 | 2,489 | 2,176 |
| Total operating expenses | 10,317 | 9,661 | 28,663 | 28,239 |
| Income from operations | 8,139 | 6,833 | 21,766 | 19,053 |
| Other income, net | 529 | 464 | 1,559 | 1,517 |
| Income before provision for income taxes | 8,668 | 7,297 | 23,325 | 20,570 |
| Provision for income tax expense | 2,162 | 1,721 | 5,783 | 4,532 |
| Net income | $6,506 | $5,576 | $17,542 | $16,038 |
| Net income per share: | ||||
| Basic | $0.51 | $0.44 | $1.37 | $1.26 |
| Diluted | $0.51 | $0.43 | $1.37 | $1.25 |
| Weighted average shares outstanding: | ||||
| Basic | 12,787 | 12,721 | 12,784 | 12,717 |
| Diluted | 12,877 | 12,860 | 12,873 | 12,842 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.